logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. The Oncology Institute "Prof. Dr. Ion Chiricuţă" Cluj-Napoca

+40264598362
office@iocn.ro
Source: Site record.
https://iocn.ro

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Oncology Institute Prof Dr Ion Chiricuta (IOCN) is one of Romania’s leading centers for cancer diagnosis, treatment, and research, located in Cluj-Napoca. Named after Ion Chiricuta, the institute plays a vital role in the national oncology network and serves as a major referral center for complex cancer cases. The institute offers comprehensive oncology services, including medical oncology, surgical oncology, radiation therapy, and palliative care. It is equipped with modern technologies that support advanced diagnostics and personalized treatment approaches. IOCN is particularly known for its multidisciplinary care model, ensuring coordinated treatment plans tailored to individual patients. In addition to clinical services, the institute is actively involved in scientific research and participates in international clinical trials, contributing to advancements in cancer therapy. It also plays an important role in medical education and training, supporting the development of…

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
36Total Trials
Source: Trial-derived.
11Recruiting Trials
Source: Trial-derived.
27Active Trials
Source: Trial-derived.
9Completed Trials
Source: Trial-derived.
40Unique Conditions
Source: Trial-derived.
40Unique Sponsors

Conditions

Source: Trial-derived. Cancer (3)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (3)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Melanoma (2)Source: Trial-derived. Multiple Myeloma (2)Source: Trial-derived. Non-Small Cell Lung Cancer (2)Source: Trial-derived. Paroxysmal Nocturnal Hemoglobinuria (2)Source: Trial-derived. Advanced Solid Tumors (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Regeneron Pharmaceuticals (4)Source: Trial-derived. Amgen (3)Source: Trial-derived. Alma Mater Europaea - Slovenia (2)Source: Trial-derived. AstraZeneca (2)Source: Trial-derived. Biobizkaia Health Research Institute (2)Source: Trial-derived. Boehringer Ingelheim (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Complex decongestive physiotherapy
Source: AI-inferred. DNA genotyping for SIRPα polymorphism
Source: AI-inferred. Interactive web response system (IWRS) for randomisation
Source: AI-inferred. Meningococcal vaccination administration
Source: AI-inferred. Meningococcal vaccine administration
Source: AI-inferred. PIK3CA mutation testing of tumour tissue
Source: AI-inferred. RET fusion testing
Source: AI-inferred. Serum and urine protein electrophoresis with immunofixation